India's Sun Pharma gets U.S. subpoena over generic drugs pricing

MUMBAI, May 28 (Reuters) - The U.S. Department of Justice

(DoJ) has subpoenaed India's largest drugmaker Sun

Pharmaceutical Industries Ltd seeking information about

the pricing and marketing of the generic drugs it sells in the

United States, the company said on Saturday.

Read more